New blood test could catch pancreatic cancer before it’s too late

Researchers have developed a novel blood test capable of detecting pancreatic cancer at early stages with over 90% accuracy, potentially transforming outcomes for one of the deadliest malignancies. The test combines two newly discovered blood proteins with existing biomarkers to create a four-marker panel that performs especially well in early-stage disease, when curative treatment is still possible. Pancreatic cancer is typically diagnosed late, contributing to its five-year survival rate of under 12%, making reliable early detection a critical unmet need. If validated in larger prospective studies, the test could eventually be used for screening high-risk populations.